Carvedilol Tablet, Film Coated
Product Images NDC 50090-2175
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 50090-2175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-2 (Figure 2)
Figure-3 (Figure 3)
The text is a figure caption showing the survival analysis for the CAPRICORN (intent-to-treat) study using carvedilol and placebo. It includes the number of patients, the treatment type, and the P-value of the analysis. The x-axis shows the time in months, and the y-axis shows the number of patients who survived.*
Figure-4 (Figure 4)
This is a table or figure in a scientific study, which shows the effects of various subgroups on mortality for a study called CAPRICORN. The subgroups are divided based on age, gender, use of diuretics, time post MI, hypertension, diabetes, Killip score, heart rate, and treatment received (thrombolytic, PTCA). The hazard ratios for different variables and subgroups are shown in the table. The text does not provide any further information about the study or its findings.*
Label Image (Lbl500902066)
Label Image (Lbl500902119)
Label Image (Lbl500902175)
Label Image (Lbl500902555)
Carvedilol-chemical-structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.